Veloxis Pharmaceuticals
Manufacturing · 11-50 Employees
View Company Info for Free
Overview
Phone Number
(919) 591-3090Website
www.envarsusxr.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Veloxis Pharmaceuticals
ENVARSUS XR is an extended-release prescription medication designed to aid in the prevention of organ rejection in patients who have undergone a kidney transplant. This product is often used in conjunction with other immunosuppressive therapies. Intended for kidney transplant recipients, as well as their caregivers and healthcare providers, ENVARSUS XR offers support resources and potential financial assistance for eligible patients. It is important for users to be informed about the associated health risks and proper administration of the medication.Explore more
Popular SearchesVeloxis Pharmaceuticals IncEnvarsus XRENVARSUS XR ( tacrolimus extendedSIC Code 28,283NAICS Code 32,325Show more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Veloxis Pharmaceuticals your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Earning: See what the market has to say on Veloxis Pharmaceuticals recently announced quarterly report
Check if Veloxis Pharmaceuticals has recently received funding, and reach out quickly before it becomes old news!
Check out if Veloxis Pharmaceuticals is spiking on competitors!
Click to see if Veloxis Pharmaceuticals had a recent Job posting/layoffs
Veloxis Pharmaceuticals, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Veloxis Pharmaceuticals has new funding data
Product Launch: Get notified when Veloxis Pharmaceuticals launches new products
Congratulate Masked Content for being promoted to Masked Content at Veloxis Pharmaceuticals
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Recommended Actions
Reach out to Masked Content who joined Veloxis Pharmaceuticals as Masked Content
Find 3 more new buyers
Compare Similar Companies to Veloxis Pharmaceuticals
Compare insights from companies similar to Veloxis Pharmaceuticals, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Veloxis Pharmaceuticals
<$5M
11-50
Private
-
-
N/A
Company Profile Activity
Activity Insights
Veloxis Pharmaceuticals is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Veloxis Pharmaceuticals is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Veloxis Pharmaceuticals.
Veloxis Pharmaceuticals Tech Stack
A closer look at the technologies used by Veloxis Pharmaceuticals
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Veloxis Pharmaceuticals
Sign Up For FreeTo access detailed company insights
ENVARSUS XR is an extended-release prescription medication designed to aid in the prevention of organ rejection in patients who have undergone a kidney transplant. This product is often used in conjunction with other immunosuppressive therapies. Intended for kidney transplant recipients, as well as their caregivers and healthcare providers, ENVARSU... Read More
